Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Apr 17, 2026 · Filed Apr 20, 2026
The money chief of Hims & Hers Health sold $501K of Hims & Hers Health shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$501,158
Shares × reported transaction price
53 days after results of Feb 23, 2026, 24 days before results of May 11, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −6.2% | +1.1% | −7.3% |
| 30 days | −19.3% | +5.5% | −24.8% |
| 90 days | +9.9% | +5.4% | +4.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$188K of Hims & Hers Health
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.